<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05026437</url>
  </required_header>
  <id_info>
    <org_study_id>SU2019</org_study_id>
    <nct_id>NCT05026437</nct_id>
  </id_info>
  <brief_title>CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting</brief_title>
  <acronym>CASUS</acronym>
  <official_title>The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Antalya Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haydarpasa Numune Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Antalya Training and Research Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study seeks to determine the value of CASUS in predicting mortality as compared with&#xD;
      APACHE II scoring system among patients undergoing coronary artery bypass grafting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing coronary artery bypass grafting will prospectively studied after the&#xD;
      admission to the cardiac intensive care unit. Data on the preoperative condition,&#xD;
      intraoperative parameters, and postoperative course will collected. CASUS and APACHE II&#xD;
      scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day&#xD;
      mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of&#xD;
      stay in the cardiac surgical intensive care unit and in the hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2, 2019</start_date>
  <completion_date type="Actual">April 10, 2019</completion_date>
  <primary_completion_date type="Actual">March 10, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Mortality at 7 days</measure>
    <time_frame>7 days</time_frame>
    <description>Mortality in the first 7 days after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality in the first 30 days after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the cardiac intensive care unit</measure>
    <time_frame>Up to 3 months (Through study completion)</time_frame>
    <description>Only the length of the initial stay in the cardiac intensive care unit up to 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of the stay in the hospital</measure>
    <time_frame>Up to 3 months (Through study completion)</time_frame>
    <description>It includes the period from surgery to discharge</description>
  </secondary_outcome>
  <enrollment type="Actual">204</enrollment>
  <condition>Coronary Artery Bypass Grafting</condition>
  <condition>Mortality</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac surgery score and APACHE II scoring</intervention_name>
    <description>Cardiac surgery score and APACHE II will calculated on the first postoperative day.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population includes all adult patients who undergoing coronary artery bypass grafting&#xD;
        during the study period.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Undergoing coronary artery bypass grafting&#xD;
&#xD;
          -  Over 18 years of age&#xD;
&#xD;
          -  Staying at least 24 hours in the cardiac intensive care unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nihan YAPICI</last_name>
    <role>Study Director</role>
    <affiliation>Dr. Siyami Ersek Thoracic and Cardiovascular Surgery TRH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sümeyye UĞUR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haydarpaşa Numune Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital in Turkey</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Haydarpasa Numune Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Sumeyye Ugur</investigator_full_name>
    <investigator_title>drsumeyyeugur@gmail.com</investigator_title>
  </responsible_party>
  <keyword>cardiac surgery score, mortality, ICU</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

